Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYNE
5276
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $49K | ﹤0.01% |
5,827
+5,201
| +831% | +$55K |
|
|
PNK
5277
CALL
DELISTED
Pinnacle Entertainment Inc.
PNK
| $49K | ﹤0.01% |
2,300
-1,000
| -30% | -$19.7K |
|
5278
Braskem
BAK
$909M
| $48K | ﹤0.01% |
+1,807
| New | +$44.4K |
|
5279
Calix
CALX
$2.49B
| $48K | ﹤0.01% |
9,499
-7,232
| -43% | -$41.3K |
|
|
CVGW
5280
DELISTED
Calavo Growers
CVGW
| $48K | ﹤0.01% |
660
-4,374
| -87% | -$310K |
|
5281
eHealth
EHTH
$45.1M
| $48K | ﹤0.01% |
1,991
-19,757
| -91% | -$402K |
|
5282
PUT
Main Street Capital
MAIN
$5.31B
| $48K | ﹤0.01% |
+1,200
| New | +$47.1K |
|
5283
PUT
Bank OZK
OZK
$5.7B
| $48K | ﹤0.01% |
+1,000
| New | +$44.5K |
|
5284
QCR Holdings
QCRH
$1.72B
| $48K | ﹤0.01% |
1,044
-4,175
| -80% | -$188K |
|
5285
PUT
Wendy's
WEN
$1.46B
| $48K | ﹤0.01% |
3,100
+1,900
| +158% | +$29.1K |
|
|
CAA
5286
PUT
DELISTED
CalAtlantic Group, Inc.
CAA
| $48K | ﹤0.01% |
1,300
-6,600
| -84% | -$235K |
|
5287
Cogent Communications
CCOI
$666M
| $47K | ﹤0.01% |
965
-6,493
| -87% | -$288K |
|
5288
CALL
Fidelity National Information Services
FIS
$22.9B
| $47K | ﹤0.01% |
500
+300
| +150% | +$27.3K |
|
|
5289
PUT
Fidelity National Information Services
FIS
$22.9B
| $47K | ﹤0.01% |
+500
| New | +$45.4K |
|
5290
Forward Air
FWRD
$484M
| $47K | ﹤0.01% |
815
-4,445
| -85% | -$235K |
|
|
GLDD
5291
DELISTED
Great Lakes Dredge & Dock
GLDD
| $47K | ﹤0.01% |
9,717
-17,925
| -65% | -$74.8K |
|
5292
Marten Transport
MRTN
$1.22B
| $47K | ﹤0.01% |
3,384
-3,706
| -52% | -$42K |
|
5293
iShares MSCI Turkey ETF
TUR
$214M
| $47K | ﹤0.01% |
1,131
| – | – |
|
5294
Vicor
VICR
$10.4B
| $47K | ﹤0.01% |
1,996
+79
| +4% | +$1.49K |
|
|
BGG
5295
PUT
DELISTED
Briggs & Stratton Corp.
BGG
| $47K | ﹤0.01% |
2,000
+1,000
| +100% | +$22.7K |
|
|
EMKR
5296
DELISTED
Emcore Corp
EMKR
| $47K | ﹤0.01% |
570
+563
| +8,043% | +$54.5K |
|
5297
CALL
Amkor Technology
AMKR
$13.9B
| $46K | ﹤0.01% |
4,400
-3,900
| -47% | -$37.3K |
|
5298
CALL
AMN Healthcare
AMN
$1.29B
| $46K | ﹤0.01% |
1,000
+900
| +900% | +$34.4K |
|
5299
Cohen & Steers
CNS
$4.32B
| $46K | ﹤0.01% |
1,142
+1,125
| +6,618% | +$44.7K |
|
|
GPMT
5300
Granite Point Mortgage Trust
GPMT
$70M
| $46K | ﹤0.01% |
+2,478
| New | +$47.2K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.